Canada markets open in 8 hours 31 minutes

Harvard Bioscience, Inc. (HBI.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
4.10000.0000 (0.00%)
At close: 08:16AM CET
Currency in EUR

Valuation Measures4

Market Cap (intraday) 178.92M
Enterprise Value 215.96M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.66
Price/Book (mrq)2.54
Enterprise Value/Revenue 1.92
Enterprise Value/EBITDA 25.31

Trading Information

Stock Price History

Beta (5Y Monthly) 1.47
52-Week Change 349.64%
S&P500 52-Week Change 325.42%
52 Week High 35.6500
52 Week Low 32.2800
50-Day Moving Average 34.3356
200-Day Moving Average 34.3593

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 542.69M
Implied Shares Outstanding 643.68M
Float 836.5M
% Held by Insiders 16.45%
% Held by Institutions 179.28%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023


Profit Margin -2.90%
Operating Margin (ttm)-3.68%

Management Effectiveness

Return on Assets (ttm)1.36%
Return on Equity (ttm)-4.46%

Income Statement

Revenue (ttm)112.52M
Revenue Per Share (ttm)2.67
Quarterly Revenue Growth (yoy)-5.80%
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-3.26M
Diluted EPS (ttm)-0.0700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.34M
Total Cash Per Share (mrq)0.12
Total Debt (mrq)45.29M
Total Debt/Equity (mrq)60.96%
Current Ratio (mrq)2.09
Book Value Per Share (mrq)1.77

Cash Flow Statement

Operating Cash Flow (ttm)12.4M
Levered Free Cash Flow (ttm)13.87M